Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) has received a consensus rating of “Moderate Buy” from the nineteen research firms that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, sixteen have given a buy recommendation and one has issued a strong buy recommendation […]
More Stories
NovoCure’s (NVCR) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of NovoCure (NASDAQ:NVCR – Free Report) in a research report released on...
Insider Selling: Cummins Inc. (NYSE:CMI) VP Sells $798,406.56 in Stock
Cummins Inc. (NYSE:CMI – Get Free Report) VP Sharon R. Barner sold 2,163 shares of the business’s stock in a...
NVIDIA (NASDAQ:NVDA) Price Target Raised to $175.00
NVIDIA (NASDAQ:NVDA – Free Report) had its target price upped by Mizuho from $165.00 to $175.00 in a research report...
GAP (NYSE:GAP) Price Target Raised to $30.00 at Wells Fargo & Company
GAP (NYSE:GAP – Get Free Report) had its price target upped by analysts at Wells Fargo & Company from $28.00...
Eagle Asset Management Inc. Sells 43,377 Shares of Knife River Co. (NYSE:KNF)
Eagle Asset Management Inc. decreased its holdings in shares of Knife River Co. (NYSE:KNF – Free Report) by 22.4% in...
Insider Selling: Applied Optoelectronics, Inc. (NASDAQ:AAOI) Insider Sells 20,323 Shares of Stock
Applied Optoelectronics, Inc. (NASDAQ:AAOI – Get Free Report) insider Hung-Lun (Fred) Chang sold 20,323 shares of the stock in a...